New investment expands JZCP’s Jordan Health Products platform
28 July 2016
JZ Capital Partners Limited (LSE:JZCP.L or “JZCP”), the London listed fund that invests in US and European micro-cap companies and US real estate, has closed an investment in Oncology Services International, Inc. (“OSI”), its third investment through the Jordan Health Products (“JHP”) platform.
JHP was formed in 2015 by Jordan Industries International, LLC (“JII”) and JZCP to develop and execute a strategic build-up in the highly fragmented US healthcare equipment market. JZCP invested $4.529 million in the transaction.
Founded in 1985, and based in Montebello, New York, OSI is one of the world’s largest independent service and maintenance providers for radiation oncology equipment, and a leading supplier of refurbished linear accelerators, a device most commonly used for external beam radiation treatments for patients with cancer.
Ends
For further information:
Ed Berry / Kit Dunford
+44 (0) 20 3727 1143
FTI Consulting
David Zalaznick
+1 212 485 9410
Jordan/Zalaznick Advisers, Inc.
Paul Le Ray
+44 (0) 1481 745815
JZ Capital Partners
About JZCP
JZCP is a London listed fund which invests in US and European micro-cap companies and US real estate. Its objective is to achieve an overall return comprised of a current yield and capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. (“JZAI”) which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI’s experts work with the existing management of micro-cap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.
